GlycoRoads: A platform for the de novo design of glycans

GlycoRoads aims to develop an AI-driven platform for de novo glycan design using molecular dynamics simulations to create a comprehensive database, enhancing customization for therapeutic and material applications.

Subsidie
€ 150.000
2025

Projectdetails

Introduction

In the spirit of the various in silico de novo protein design products, GlycoRoads aims to introduce the world's first tool for de novo glycan design. Our cutting-edge screening platform will harness the power of molecular dynamics (MD) simulations to analyze hundreds of thousands of glycan structures, extracting crucial structural information to populate a comprehensive database (DB).

Database Development

This rich repository of data will serve as the foundation for an AI-driven user interface, designed to interrogate the DB and guide the de novo design of glycans that can adopt specific target conformations, greatly accelerating the exploration of their applications.

Importance of Glycans

The growing recognition of glycans' critical roles in biology and materials science underscores the transformative potential of our project. If successful, it will unlock unprecedented capabilities to customize glycans for targeted applications, opening new avenues in the design of next-generation therapeutics and materials.

Project Background

Within the ERC GlycoFold grant, our team has designed glycans with precise secondary structures. GlycoRoads builds on this groundwork to make the strategic design of glycans accessible to both academic and industrial researchers.

Objectives

This goal requires the completion of three critical objectives:

  1. Enhancing the current MD-based screening platform.
  2. Generating and systematically cataloging a vast array of data into a comprehensive and accessible DB.
  3. Developing an AI tool to leverage the DB to accelerate the design of glycans for diverse applications.

Anticipated Outcomes

The anticipated outcomes of our project—a detailed DB of glycan structures and a user-friendly interface for its interrogation—offer substantial commercialization prospects. Together, they pave the way for a groundbreaking shift in de novo glycan design across various fields.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-6-2025
Einddatum30-11-2026
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EVpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC STG

Glycan foldamers: designing oligosaccharides to build three-dimensional architectures

The project aims to develop synthetic carbohydrate foldamers that adopt defined structures and assemble into complex architectures, enhancing understanding and applications in chemistry and material science.

€ 1.499.956
ERC STG

Imaging Single Glycoconjugates

GlycoX develops single molecule imaging methods to elucidate glycoconjugate structures, enhancing understanding for therapeutics and diagnostics in immune response and microbial infection.

€ 2.000.000
ERC COG

Glycan Mimetics for Cell Glycocalyx Reconstitution: a polymer chemist’s approach to fight infection

GLYMCE aims to uncover how carbohydrates influence pathogen interactions to create innovative glycopolymer materials for infection prevention and treatment.

€ 1.994.024
ERC STG

Isotopically labelling of cell surface glycans to illuminate infectious processes at atomic resolution

Glyco13Cell aims to chemically remodel cell surface glycans using NMR probes to enhance understanding of glycan-lectin interactions for developing novel tools in infectious disease treatment.

€ 1.500.000